Status:
COMPLETED
Proton Therapy for Hodgkin Lymphoma
Lead Sponsor:
University of Florida
Conditions:
Hodgkin Lymphoma
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
The purpose of this study is to reduce the risk of radiation related side effects and complications by treating with radiation (protons or photons) that exposes less of normal organs to low dose radia...
Detailed Description
3 treatment plans will be created to deliver between a total of 21-39.6 Gray (Gy)/Centigray Equivalents (CGE) to the planning target volume (PTV). 1. Proton Plan 2. Conventional Plan 3. Intensity Mod...
Eligibility Criteria
Inclusion
- Confirmed "classic" Hodgkin lymphoma.
- Completed chemotherapy.
Exclusion
- Prior radiotherapy.
- Prior or concurrent cancer other than non-melanomatous skin cancer.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00850200
Start Date
August 1 2009
End Date
January 9 2018
Last Update
January 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida Proton Therapy Institute
Jacksonville, Florida, United States, 32206